Certification Rate
100%
Very high DOL cert
2026 data Public-data reference Official source
Ipsen Biopharmaceuticals, Inc.
A DOL Labor Condition Application record spanning FY2024–2025. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 6
- DOL-certified
- 100%
- Median offered wage
- $196,791
Cambridge, MA NAICS: 325411
How many H-1B LCA filings list Ipsen Biopharmaceuticals, Inc.?
U.S. Department of Labor's OFLC discloses 6 Labor Condition Application filings naming Ipsen Biopharmaceuticals, Inc. from FY2024 through FY2025, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
USCIS adjudication record for Ipsen Biopharmaceuticals, Inc.
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 2 H-1B petitions naming Ipsen Biopharmaceuticals, Inc. through FY2024, and approved nearly every one of them: 100% approved (2 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Ipsen Biopharmaceuticals, Inc. is listed in 6 DOL LCA filings, more filings than 80% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $196,791. This is not a USCIS approval, hiring, or sponsorship ranking.
- 6
- DOL LCA filings, FY2024–FY2025
- 100%
- DOL-certified
- $196,791
- median offered wage
- Top 20%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2024–FY2025). Based in Cambridge, MA.
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
Ipsen Biopharmaceuticals, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
6 28534th of 122824 higher than 94,290 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2024–FY2025
LCA filing shape · Ipsen Biopharmaceuticals, Inc.
Derived from this employer's disclosed LCAs on file (FY2024–FY2025), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $148,762–$251,250 .
Title concentration
- VP Procurement North America Commercial 1 · 16.7% · $251,250
- Senior Director, Global Partnering 1 · 16.7% · $215,250
- Senior Digital Health Manager 1 · 16.7% · $185,000
- Regulatory Submission Project Director 1 · 16.7% · $210,891
- Principal Statistical Programmer 1 · 16.7% · $169,592
Worksite counties
- CAMBRIDGE CITY, MA 6 · 100%
DOL LCA release change
What changed between the two LCA fiscal years
- Ipsen Biopharmaceuticals, Inc.'s disclosed H-1B LCA filing count rose from 1 in FY2024 to 5 in FY2025 (+400%).
Above-prevailing wage posture
On 6 LCAs with comparable offered vs prevailing wages, Ipsen Biopharmaceuticals, Inc. averages about 18.7% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (100% of LCA filings).
Cambridge City, MA worksite concentration
Only 6 LCAs on file for Ipsen Biopharmaceuticals, Inc., and 100% land in CAMBRIDGE CITY, MA. Treat rates as descriptive of a small sample. DOL cert on file: 100%.
Avg. Salary
$196,791
Well above portal avg
Total Workers
6
Small worker count
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at Ipsen Biopharmaceuticals, Inc.
Minimum
$148,762
Maximum
$251,250
Average Salary
$196,791
Wage vs. DOL Minimum
+18.7%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
100% of LCA filings
Full-Time Positions
100%
Primary Worksite County
CAMBRIDGE CITY, MA
100% of LCA filings
Top Occupations
Most frequently listed job titles at Ipsen Biopharmaceuticals, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| VP Procurement North America Commercial | 1 | $251,250 |
| Senior Director, Global Partnering | 1 | $215,250 |
| Senior Digital Health Manager | 1 | $185,000 |
| Regulatory Submission Project Director | 1 | $210,891 |
| Principal Statistical Programmer | 1 | $169,592 |
| Associate Director, Business Integrated Insights | 1 | $148,762 |
Nationwide peers near Ipsen Biopharmaceuticals, Inc.'s 6-LCA band
Cross-state DOL neighbors for Ipsen Biopharmaceuticals, Inc. - LCA filing-count and offered-wage axes, outside MA.
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($196,791 here).
What People Ask
What is Ipsen Biopharmaceuticals, Inc.'s H-1B LCA filing count?
Ipsen Biopharmaceuticals, Inc. is listed in 6 DOL Labor Condition Application filings covering 6 listed worker positions from FY2024 to FY2025. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
How does Ipsen Biopharmaceuticals, Inc.'s LCA filing volume compare to other employer filers?
Among 122,824 employer filers in the DOL disclosure extract, Ipsen Biopharmaceuticals, Inc. ranks #25162 by total LCA filing count (6 filings). 94,290 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
How often are Ipsen Biopharmaceuticals, Inc.'s LCAs certified by the Labor Department?
Ipsen Biopharmaceuticals, Inc. has a 100% DOL certification rate, with 6 out of 6 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
What does Ipsen Biopharmaceuticals, Inc. list as the offered wage on its LCAs?
The average offered wage listed in Ipsen Biopharmaceuticals, Inc.'s LCAs is $196,791. Listed wages range from $148,762 to $251,250 and are not verified actual compensation.
What roles does Ipsen Biopharmaceuticals, Inc. file the most H-1B LCAs for?
The top job titles in Ipsen Biopharmaceuticals, Inc.'s LCA filing records include VP Procurement North America Commercial, Senior Director, Global Partnering, Senior Digital Health Manager. The most common listed title is VP Procurement North America Commercial with 1 LCA filings at an average listed offered wage of $251,250. This does not establish actual job openings, hiring, or approved petitions.
Where is Ipsen Biopharmaceuticals, Inc. headquartered?
Ipsen Biopharmaceuticals, Inc. is headquartered in Cambridge, MA.
Is Ipsen Biopharmaceuticals, Inc. H-1B dependent?
No, Ipsen Biopharmaceuticals, Inc. is not classified as H-1B dependent.
How have Ipsen Biopharmaceuticals, Inc.'s listed LCA filings changed over time?
Ipsen Biopharmaceuticals, Inc. is listed in 1 LCA filings in FY2024 and 5 in FY2025. The average listed offered wage changed from $251,250 to $185,899. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
Read with Ipsen Biopharmaceuticals, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
13 Scents, Inc. · TRACE-BOOK
ABS(total_petitions) peer at 6 LCAs (Δ 0 heavier vs Ipsen Biopharmaceuticals, Inc.); CERT-SOFT · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
1and8 Inc. · TRACE-BOOK
ABS(total_petitions) peer at 6 LCAs (Δ 0 heavier vs Ipsen Biopharmaceuticals, Inc.); CERT-LOCK · WAGE-PAR vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
1connect technologies Inc · TRACE-BOOK
ABS(total_petitions) peer at 6 LCAs (Δ 0 heavier vs Ipsen Biopharmaceuticals, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
21st Mortgage Corporation · TRACE-BOOK
ABS(total_petitions) peer at 6 LCAs (Δ 0 heavier vs Ipsen Biopharmaceuticals, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
Fidelity Technology Group, LLC · LARGEST-distance pole
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Ipsen Biopharmaceuticals, Inc.'s TRACE-BOOK.
MA worksite board · TRACE-BOOK
Open the MA state board after the ABS peers. Ipsen Biopharmaceuticals, Inc. stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
Salary calculator · WAGE-ELITE
Ipsen Biopharmaceuticals, Inc.'s WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Ipsen Biopharmaceuticals, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Ipsen Biopharmaceuticals, Inc. filed 6 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 80% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in MA rank on LCA filing volume this vintage. MA filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.